1. Home
  2. NEON vs NRSN Comparison

NEON vs NRSN Comparison

Compare NEON & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.40

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.69

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
NRSN
Founded
1997
2017
Country
Sweden
Israel
Employees
N/A
15
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
24.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NEON
NRSN
Price
$1.40
$0.69
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$8.50
AVG Volume (30 Days)
99.6K
184.0K
Earning Date
05-13-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.63
52 Week High
$29.90
$2.60

Technical Indicators

Market Signals
Indicator
NEON
NRSN
Relative Strength Index (RSI) 43.34 37.54
Support Level $1.27 $0.66
Resistance Level $2.04 $1.30
Average True Range (ATR) 0.07 0.07
MACD 0.02 -0.00
Stochastic Oscillator 54.90 30.48

Price Performance

Historical Comparison
NEON
NRSN

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: